PD-L1 expression implies the presence of spontaneous T cell recognition, followed by the activation and production of IFN-γ on-site, which provides predictive values for the responses of patients with melanoma, non–small cell lung cancer, and bladder cancers to ICI monotherapy (28). The gene discussed is CD274; the disease is urinary bladder carcinoma.